[1]
Boesjes, C.M. et al. 2023. Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry. Acta Dermato-Venereologica. 103, (Feb. 2023), adv00872. DOI:https://doi.org/10.2340/actadv.v103.5243.